Last Price
13.50
Today's Change
+0.175 (1.31%)
Day's Change
13.26 - 14.03
Trading Volume
45,480
Market Cap
554 Million
Shares Outstanding
41 Million
Avg Volume
159,904
Avg Price (50 Days)
12.34
Avg Price (200 Days)
11.44
PE Ratio
-16.46
EPS
-0.82
Earnings Announcement
07-Nov-2024
Previous Close
13.32
Open
13.52
Day's Range
13.2652 - 14.03
Year Range
5.765 - 16.94
Trading Volume
45,480
1 Day Change
1.31%
5 Day Change
-9.76%
1 Month Change
14.12%
3 Month Change
3.85%
6 Month Change
43.01%
Ytd Change
20.11%
1 Year Change
117.04%
3 Year Change
-20.59%
5 Year Change
-20.59%
10 Year Change
-20.59%
Max Change
-20.59%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.